After-Hours Surge Boosts PALI, HCTI, NTRB, KPTI, EDIT, and CGON Amid Mixed News and Strategic Actions
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 10 2025
0mins
Source: NASDAQ.COM
Palisade Bio Inc. Update: Palisade Bio's shares rose 7.62% to $2.26 after the cancellation of a special stockholder meeting due to lack of quorum, leading to the withdrawal of all proposals from consideration.
Healthcare Triangle Inc. Acquisition: Healthcare Triangle's stock increased by 4.35% to $2.88 following the announcement of a non-binding Letter of Intent to acquire Teyame.AI, which is expected to generate $34 million in revenue for fiscal year 2025.
Nutriband Inc. Patent Filing: Nutriband's shares gained 4.30% to $8.25 after the company filed a provisional patent application to enhance its intellectual property for its AVERSA abuse deterrent technology.
Karyopharm Therapeutics Financing: Karyopharm's stock rose 4.46% to $6.08 after announcing financing transactions that will provide $100 million in financial flexibility, extending its cash runway into the second quarter of 2026.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like HCTI with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on HCTI
About HCTI
Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing industry-transforming in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. The Company operates through three segments: Software Services, Managed Services and Support, and Platform Services. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its Platform Services segment includes CloudEz, DataEz, Niyama and Readabl.AI platforms. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers in their efforts to improve data management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare Triangle Shares Surge After $50M Acquisition of Spanish Firms
- Acquisition Completed: Healthcare Triangle Inc. has successfully acquired Spanish companies Teyamé 360 S.L. and Datono Mediación S.L. through its subsidiary Teyame AI Holdings Inc., with a total transaction value of up to $50 million, marking a significant step in the company's international expansion.
- Stock Price Surge: Following the acquisition announcement, Healthcare Triangle's shares rose 34.34% in after-hours trading to $0.40, indicating a positive market reaction despite a staggering 99.85% decline in stock price over the past year.
- Equity Structure: The equity consideration for the deal includes $12 million in restricted common stock and $18 million in convertible preferred stock, along with an additional earnout of up to $5 million tied to performance targets, aimed at incentivizing the management of the acquired companies.
- Market Performance Analysis: With a Relative Strength Index (RSI) of 19.13, Healthcare Triangle's stock is under significant pressure, currently valued at $3.28 million and trading near its 52-week low, necessitating clear signs of recovery to improve market sentiment.
Continue Reading
Healthcare Triangle Partners with Better to Expand Digital Health Solutions
- Strategic Partnership Agreement: Healthcare Triangle has signed a Development Program Agreement with global digital healthcare platform provider Better, marking a significant step for HCTI in advancing digital health innovation across Southeast Asia, the Middle East, and Africa, which is expected to enhance its market share and service capabilities.
- Enhanced Technical Capabilities: Under this agreement, QuantumNexis and other HCTI subsidiaries will gain access to Better's training and certification programs, thereby strengthening their expertise and delivery capabilities in the digital health sector, further driving the digital transformation of healthcare services.
- Market Expansion Potential: This collaboration positions HCTI and QuantumNexis to pursue digital health opportunities in rapidly growing markets such as Europe, Southeast Asia, the Middle East, and Africa, which is expected to provide improved healthcare services to millions of patients and enhance patient care outcomes.
- Advocacy for Open Data Standards: Better's International Markets Director stated that this partnership will promote the adoption of open electronic health records, leveraging modern platform technology to enable healthcare innovation, assisting providers in building interoperable, future-proof systems focused on patient outcomes.
Continue Reading